FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)

Kalshi Closes Dec 31 · 4.1K contracts · prices read 2 min ago

The odds

93%chance▲ 1

How the odds have moved

Yes: 90% on Oct 3, 93% now.

Each outcome's chance over time, from its prices on Kalshi.

Related markets

All stocks & companies ›

Anthropic IPO by __?

Nov 25, 2026even chance by
  • November 15, 20261%
  • November 16, 20264%▲ 2
  • November 17, 20265%▼ 5
  • November 18, 20269%▼ 10
8 more
  • November 19, 202624%▼ 13
  • November 20, 202641%▼ 17
  • November 23, 202649%▼ 19
  • November 24, 202649%▼ 19
  • November 25, 202656%▼ 17
  • November 30, 202661%▼ 21
  • December 15, 202668%▼ 20
  • December 31, 202668%▼ 20

Anthropic IPO Closing Market Cap

25%$1.5–$1.75T
  • $1.5–$1.75T25%▼ 1
  • $1.75–$2.0T22%▼ 5
  • $2.0–$2.25T16%
  • $1.25–$1.5T16%▲ 5
6 more
  • <$1.25T11%
  • $2.25–$2.5T4%▼ 1
  • No IPO by December 31, 20273%▲ 3
  • $2.5–$2.75T2%
  • $2.75–$3.0T1%
  • $3.0T+<1%▼ 1

Will Anthropic’s valuation hit __ by December 31?

$2.01Thigh with an even chance

Traders see an even chance of trading as high as $2.01T.

  • Reaches $1.5T79%
  • Reaches $1.75T63%
  • Reaches $2T51%
  • Reaches $2.25T26%
  • Falls to $800B4%
  • Falls to $700B2%
  • Falls to $600B1%

Already reached: ↑$1.25T, ↑$1.1T, ↑$1.0T

Odds are traders' prices on Kalshi and Polymarket, not forecasts by 4SEARCH.business. Read from the venues just now. Prices may be delayed up to 15 min. Not investment advice.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance